← Back to Search

Behavioural Intervention

Warm Water Immersion for Temperature Regulation in Aging

N/A
Waitlist Available
Led By Glen P Kenny, PhD
Research Sponsored by University of Ottawa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Must not have
Episode(s) of severe hypoglycemia within the previous year, or inability to sense hypoglycemia
Serious complications related to diabetes (gastroparesis, renal disease, uncontrolled hypertension, severe autonomic neuropathy)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of 10 hour daylong heat exposure
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the effectiveness of a 7-day passive heating protocol in older women to help them cope with indoor overheating. The study will involve warm-water immersion to see if it can reduce

Who is the study for?
This trial is for older females who may be vulnerable to heat-related issues due to lack of air-conditioning or reliable electricity. It's designed to help them become more resistant to heat by using warm-water baths. Participants should not have conditions that prevent them from safely experiencing increased temperatures.
What is being tested?
The study tests if soaking in warm water can make older women better at handling extreme indoor heat, without exercising. For seven days, they'll immerse in warm water with their core temperature maintained around 38.5°C for the last hour, and then face an 8-hour indoor heat challenge.
What are the potential side effects?
Potential side effects might include discomfort from prolonged warmth, dizziness or lightheadedness due to increased body temperature, and cardiovascular strain which could be risky for those with heart problems.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I've had severe low blood sugar or can't tell when my sugar is low in the last year.
Select...
I do not have severe diabetes complications like kidney disease or uncontrolled high blood pressure.
Select...
My blood pressure is not higher than 150/95 mmHg.
Select...
My illness limits my physical activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of 10 hour daylong heat exposure
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of 10 hour daylong heat exposure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Arousal scale during daylong heat exposure
BTrackS Balance Assessment (Postural stability) during daylong heat exposure
CDC 4-Stage Balance Test (Postural stability) during daylong heat exposure
+21 more
Secondary study objectives
Environmental Symptoms Questionnaire (ESQ)
Muscle oxygen during battery of cardiovascular, cognition and postural stability tests during daylong heat exposure
Profiles of Mood States (POMS) during daylong heat exposure
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Daylong exposure to indoor overheatingExperimental Treatment1 Intervention
Prior to and following the warm-water immersion protocol, participants will undergo a 10-hour passive heat exposure where they will remain in a climate-controlled chamber regulated at 36°C and 45% humidity (temperatures experienced indoors during extreme heat events in North America). During this time they will remain seated with the exception of hourly 5-minute breaks to stretch.

Find a Location

Who is running the clinical trial?

University of OttawaLead Sponsor
221 Previous Clinical Trials
269,637 Total Patients Enrolled
9 Trials studying Aging
442 Patients Enrolled for Aging
Glen P Kenny, PhDPrincipal InvestigatorUniversity of Ottawa
10 Previous Clinical Trials
285 Total Patients Enrolled
6 Trials studying Aging
193 Patients Enrolled for Aging
~8 spots leftby May 2025